ionic minerals logo

Research on fibromyalgia syndrome

The following articles are presented as support for the possible use of ionic minerals as a dietary supplement and nutritional supplement for natural therapy. You will find more on fibromyalgia here. You can also purchase this diet supplement disease treatment package below.

FIBROMYALGIA SYNDROME

Magazine: British Medical Journal; February 11, 1995
Section: Education & Debate

ABC of Rheumatology

Fibromyalgia is common in hospital practice. It is rarely reported in children, and most patients are in their 40s or 50s. In all settings there is a strong female preponderance (about 90%). It is well reported in the United States, Canada, and Europe, but racial and social predisposition have not been adequately addressed.

Symptoms are variable. Pain and fatiguability are usually prominent and associated with considerable disability and handicap. Although patients can usually dress and wash independently, they cannot cope with a job or ordinary household activities. Pain is predominently axial and diffuse but can affect any region and may at times be felt all over. Characteristically, analgesics, non-steroidal anti-inflammatory drugs, and local physical treatments are ineffective and may even worsen symptoms.

Patients often have a poor sleep pattern with considerable latency and frequent arousal. Typically they awake exhausted and feel more tired in the morning than later in the day. Unexplained headache, urinary frequency, and abdominal symptoms are common and may have been extensively investigated with no cause found. Patients usually score highly on measures of anxiety and depression.

Although the term fibromyalgia syndrome is not ideal, it does not imply causation and describes the commonest symptom. Idiopathic diffuse pain syndrome, generalised rheumatism, and non-restorative sleep disorder are terms that are increasingly preferred by some.

Clinical signs

Clinical findings are unremarkable, and the principal positive sign is the presence of multiple hyperalgesic tender sites. In normal subjects these tender sites are uncomfortable to firm pressure, but in patients with fibromyalgia similar pressure produces a wince or withdrawal response. The degree of pressure is clearly important; delivery of standard pressure with a spring device (dolorimeter) is ideal, but reasonable palpation suffices for clinical purposes.

Hyperalgesia at one or two sites in the same quadrant often results from periarticular lesions or referred tenderness from an axial structure. In fibromyalgia, however, hyperalgesia is widespread and symmetrical. The number of tender sites required by different diagnostic criteria varies, but eight or more are sufficient for clinical purposes. Importantly, hyperalgesia is absent at sites that are normally non-tender. If a patient claims to be tender all over, fabrication or psychiatric disturbance (psychogenic rheumatism) is more likely. Osteoarthritis and periarticular syndromes are common and may be present as incidental findings or as a trigger for the syndrome.

Differential diagnosis

Other conditions that may present with widespread pain, weakness, or fatigue should be excluded by a limited investigational screen. Further tests may be warranted if a patient's history and examination suggest a predisposing or coexistent condition. Undertaking all investigations together reinforces the patient's confidence in the accuracy of the diagnosis and is preferable to a drawn out sequence of tests. Fibromyalgia may superimpose on pre-existing painful conditions such as osteoarthritis or cancer but usually affects subjects with no other diagnosis (primary fibromyalgia).

Nature of fibromyalgia

The pathogenesis of the syndrome remains unclear. Clinical heterogeneity is pronounced, and multiple factors are likely to relate to its development and chronicity. Depending on the predominant symptom, fibromyalgia may be categorised under various diagnostic labels. These conditions overlap and probably represent different expressions in a spectrum of abnormality. Medicine has a traditional bias towards a pathological explanation of disease, but with fibromyalgia there is no investigational evidence of overt inflammatory, metabolic, or structural abnormality and the problem appears functional rather than pathological.

Sleep disturbance

A strong association with sleep disturbance is suggested by:

· An increased frequency of non-restorative sleep

· Electroencephalographic evidence of reduced deep non-rapid eye movement (non-REM) sleep with interruption by a waves (a-d intrusion)

· Reproduction of fibromyalgia symptoms and hyperalgesic tender sites in normal subjects by selective deprivation of non-REM (but not REM) sleep.

Chronic non-restorative sleep f8 has been suggested as a possible cause. Various factors (such as regional pain syndrome, bereavement, and anxiety) cause reduced deep sleep, with resultant somatic symptoms and fatigue. Once reduced sleep has been established, reduced activity, declining aerobic fitness, and pain encourage perpetuation of this aberrant sleep pattern.

Other possible causes

Deficiency of serotonin (or its precursor tryptophan) and other abnormalities of the neuroendocrine axis have been proposed as mechanisms to explain both the sleep disorder and pain associated with fibromyalgia. Whether these reported abnormalities are cause or effect remains uncertain.

Vital aetiology has been proposed for patients with some forms of chronic fatigue syndrome, but evidence for triggering viral infections in most patients with fibromyalgia is lacking.

Affective symptoms are common, though whether they are primary or secondary remains unclear. In fibromyalgia the predominance of locomotor pain, presence of multiple hyperalgesic tender sites, development after selective sleep deprivation, and different response to treatment argue for differentiation from anxiety or depression with somatisation.

Management

There is no specific treatment for this condition, but individual patients may be considerably helped. The single most important intervention is a comprehensible explanation. Most patients expect a pessimistic cause for their devastating symptoms, and they should be reassured that the pain does not reflect cancer, inflammation, or structural damage. An explanation based on poor sleep and reduced fitness is readily understood and helps patients to rationalise their symptoms, disability, and treatments. It is helpful to include family members. Inquiry about life events may reveal problems that merit open discussion and counselling. Patients with sublimated anxiety are more likely to improve if their anxiety is identified and successfully addressed.

Controlled trials have confirmed the usefulness of low dose amitdptyline or dothiepin (25-75 mg at night) and a graded exercise programme to increase aerobic fitness.

Amitriptyline--The dose used is lower than that for depression. Its efficacy may be due to its normalising effects on the sleep centre or pain gating at the spinal cord level. Interestingly, cyclobenzaprine (a tricyclic muscle relaxant with no antidepressant action) is also effective. If these drugs are ineffective after a trial of four to six weeks, further drug treatment should be avoided. Benzodiazepines and other hypnotics have no place in treatment.

Increasing aerobic exercise is intended to improve sleep and restore fitness. It may initially exacerbate symptoms, but patients should be encouraged to continue despite pain (the opposite advice to that for someone with synovitis or joint damage). An important element is that the locus of control is now within the patient--it is up to them, not doctors or drugs, to improve their situation.

Operant and other illness behaviour is common. This needs to be recognised and eliminated by educating family members.

Coping strategies (such as meditational yoga) may permit patients to better control the extent to which pain and fatigue intervene in their life.

Prognosis

The prognosis for fibromyalgia is poor. In one British study less than one in 10 patients diagnosed in hospital lost their symptoms over five years. Nevertheless, suitable advice can help most patients to learn to cope better with their condition and, importantly, to avoid further unnecessary investigations and drug treatments.

Prevalence of fibromyalgia

Rheumatology clinics 20%
Internal medicine clinics 6%
Family practice clinics 2%
General medical inpatients (United Kingdom) 5%
General population (Swedish city, British general practice) 1%

Principal symptoms of fibromyalgia

Pain
Predominantly axial (neck and back), but may be all over
Often aggravated by stress, cold, and activity
Often associated with generalised morning stiffness
Often with subjective swelling of extremities
Paraesthesiae and dysaesthesiae of hands and feet
Fatiguability
Often extreme, occurring after minimal exertion
Non-restorative sleep
Waking unrefreshed
Poor concentration and forgetfulness
Low affect, irritable, and weepy
Headache
Occipital and bifrontal
Diffuse abdominal pain and variable bowel habit
Urinary frequency
Urgency (day and night)
Dysmenorrhoea

Principal clinical findings

· Discordance between symptoms and disability and objective findings

· No objective weakness, synovitis, or neurological abnormality

· Multiple hyperalgesic tender sites {axial and upper and lower limbs)

· Pronounced tenderness to rolling of skin fold (mid-trapezius)

· Cutaneous hyperaemia after palpation of tender sites or rolling of skin fold

· Negative control (non-tender) sites (such as forehead, distal forearm, and lateral fibular head)

Common hyperalgesic tender sites

· Low cervical spine (C4-C6 interspinous ligaments)

· Low lumbar spine (L4-S1 interspinous ligaments)

· Suboccipital muscle (posterior base of skull) * Mid-supraspinatus

· Mid-point of upper trapezius

· Pectoralis insertion--maximal lateral to second costochondral junction

· Lateral epicondyle--tennis elbow sites, 1-2 cm distal to epicondyle

· Gluteus medius--upper, outer quadrant of buttock

· Greater trochanter

· Medial fat pad of knee

Differential diagnosis and investigations

Differential diagnosis Investigation
Hypothyroidism Thyroid function tests

Systemic lupus Full Blood count
erythematosus Erythcrocyte sedimentation
 rate and blood viscosity

Inflammatory myopathy Creatine kinase concentration

Hyperparathyroidism Calcium concentration and alkaline
Osteomalacia phosphatase concentration

Diagnostic terms that often include patients with fibromyalgia

Principal presenting symptom Diagnostic level
Locomotor pain Psychogenic rheumatism
 Fibrositis
 Pain amplification syndrome

Fatigue Myalgic encephalomyelitis
 Chronic fatigue syndrome

Headache Tension headache
Abdominal pain and bowel Irritable bowel syndrome
disturbance
Frequency and nocturia Female urethral syndrome

Whether the cause of fibromyalgia (such as signal misinterpretation, psychoneuroendocrine disorder, or aberrant pain mechanism) is peripheral or central remains unclear and may differ between patients

Principal strategies for managing fibromyalgia

· Educate patient

· Educate patient's family

· Avoid unnecessary investigations and treatments

· Use interventions to correct non-restorative sleep, improve aerobic fitness, and reinforce intrinsic locus of control

Interventions for managing fibromyalgia

Low dose amitriptyline
Initially a limited trial of 4-6 weeks

Graded aerobic exercise regimen
Individualised to patient
Set specified targets that increase weekly
Encourage small amounts often
Encourage continuation despite pain
Retrain to avoid operant behaviour

Coping strategies
Meditational yoga
Behavioural therapy

PHOTO (COLOR): Typical hyperalgesic withdrawal response by patient with fibromyalgia. {Picture reproduced with patient's permission.)

PHOTO (COLOR): Common hyperalgesic tender site

PHOTO (COLOR): Palpation of hyperalgesic tender sites: (top left) medial fat pad of knee, (top right) site of muscle insertion at occiput, and (left) greater trochanter of femur.

DIAGRAM: Possible mechanism of induction and perpetuation of fibromyalgia.

~~~~~~~~

Michael Doherty, Adrian Jones

Michael Doherty is reader in rheumatology and Adrian Jones is senior registrar at the Rheumatology Unit, City Hospital, Nottingham

The ABC of Rheumatology is edited by Michael L Snaith, senior lecturer in rheumatology at Nether Edge Hospital, Sheffield.

back.gif

Order Fibromyalgia Natural Remedy Package
By Credit Card Now:

ITEM DEscriptION PRICE
FIBRO30 30-day supply: Calcium (1gal.), Copper (16oz.), Magnesium (1gal.), Manganese (16oz.), Platinum (32oz.), Sulfur (1gal.), Water of Life (32oz.), Zinc (32oz.), Vitamin C (250ct.)

$375.00
$320.00

Add to Shopping Cart

FIBRO90 90-day supply: Calcium (2gal.), Copper (16oz.), Magnesium (2gal.), Manganese (1gal.), Platinum (1gal.), Sulfur (2gal.), Water of Life (1gal.), Zinc (1gal.), Vitamin C (500ct.)

$635.00
$540.00

Add to Shopping Cart

OR

shopcartView Shopping Cart  /  Checkout


See More Research
See More Fibromyalgia Research
Back to Disease Treatment Natural Therapy Section


[HOME]
[DISEASE TREATMENT NATURAL THERAPY]
[ONLINE CATALOGUE | MAIL ORDER FORM]
[ORDERING & SHIPPING POLICY | CONTACT INFORMATION]

Please send Email to: questions@ionicminerals.com


The information contained herein is for educational purposes only. It is not medical advice and is not intended to replace the advice or attention of health care professionals. Consult your physician before beginning or making changes in your diet, supplements or exercise program, for diagnosis and treatment of illness and injuries, and for advice regarding medications.

Copyright ©1999-2001 IonicMinerals.com


ionic minerals logo




visit the home page


online product catalogue


online product catalogue


popular links with Ionic Minerals.com


ordering and shipping policies


contact us


about Ionic Minerals.com ionic minerals




ATTENTION!
INTERNATIONAL VISITORS
CLICK HERE